CAS 1177261-73-2

Formule : C19H24N4O5

InChI : InChI=1S/C19H24N4O5/c1-26-15-10-12-13(11-16(15)27-2)20-19(21-17(12)24)23-7-5-22(6-8-23)18(25)14-4-3-9-28-14/h10-11,14H,3-9H2,1-2H3,(H,20,21,24)

Code InChI : SOPCVLMNPKFJKQ-UHFFFAOYSA-N

SMILES : COC1=C(C=C2C(=C1)C(=O)NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)OC

Terazosin Related Compound B

CAS : 1177261-73-2

Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi

Formule : C₁₉H₂₄N₄O₅

Couleur et forme : White Powder

Masse moléculaire : 388.17467

Ref: 45-1643474

Terazosin EP Impurity B

Produit contrôlé

CAS : 1177261-73-2

Formule : C₁₉H₂₄N₄O₅

Couleur et forme : Neat

Masse moléculaire : 388.42

Ref: 86-MM0843.02

6,7-Dimethoxy-2-(4-(tetrahydrofuran-2-carbonyl)piperazin-1-yl)quinazolin-4(1H)-one

Produit contrôlé

CAS : 1177261-73-2

Applications 6,7-Dimethoxy-2-(4-(tetrahydrofuran-2-carbonyl)piperazin-1-yl)quinazolin-4(1H)-one is an analogue of Terazosin (T105000), an α-1-adrenergicblocker related to prazosin (P702325).
References Patterson, S.E., et al.: J. Chromatog., 311, 206 (1984), Fort, F.L., et al.: Drug Chem. Toxicol., 7, 435 (1984), Lepor, H., et al.: J. Urol., 148, 1467 (1992),

Formule : C₁₉H₂₄N₄O₅

Couleur et forme : Neat

Masse moléculaire : 388.42

Ref: TR-D471180

Terazosin EP Impurity B

CAS : 1177261-73-2

Formule : C₁₉H₂₄N₄O₅

Masse moléculaire : 388.42

Ref: ST-EA-CP-T17002

6,7-Dimethoxy-2-[4-[(tetrahydro-2-furanyl)carbonyl]-1-piperazinyl]-4(3H)-quinazolinone

CAS : 1177261-73-2

6,7-Dimethoxy-2-[4-[(tetrahydro-2-furanyl)carbonyl]-1-piperazinyl]-4(3H)-quinazolinone is a drug product. It is an analytical standard for the impurity of CAS No. 1177261-73-2. This compound has been synthesized by custom synthesis and its purity is high. The compound has been used in research and development of drugs, pharmacopoeia, HPLC standards, and other related fields.

Formule : C₁₉H₂₄N₄O₅

Degré de pureté : Min. 95%

Masse moléculaire : 388.42 g/mol

Ref: 3D-ID63842